User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines

Jaclyn A Shepard; Marc  Breton; Revital Nimri; Joseph Roberts; Timothy  Street; David  Klonoff; Katharine  Barnard-Kelly

doi:https://doi.org/10.1177/1932296820957728

User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines

Jaclyn A Shepard , Marc Breton , Revital Nimri , Joseph Roberts, Timothy Street , David Klonoff , Katharine Barnard-Kelly

Birmingham Law School

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

A growing number of individuals with type 1 diabetes are choosing to use “do-it-yourself” artificial pancreas systems (DIY APS) to support their diabetes self-management. Observational and self-report data of glycemic benefits of DIY APS are promising; however, without rigorous clinical trials or regulation from governing bodies, liability and user safety continue to be central concerns for stakeholders. Despite DIY APS having been used for several years now, there are no guidelines to assist users and healthcare professionals in addressing DIY APS use in routine clinical care. This commentary reports key stakeholders’ perspectives presented at the annual Advanced Technologies and Treatments in Diabetes conference in February 2020. Important considerations to inform the development of clinical care guidelines are also presented to generate further debate.

Original language	English
Journal	Journal of Diabetes Science and Technology
DOIs	https://doi.org/10.1177/1932296820957728
Publication status	Published - 1 Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://doi.org/10.1177/1932296820957728

Cite this

@article{b7dec155efe746d0a2b10983e61b2b29,

title = "User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines",

abstract = "A growing number of individuals with type 1 diabetes are choosing to use “do-it-yourself” artificial pancreas systems (DIY APS) to support their diabetes self-management. Observational and self-report data of glycemic benefits of DIY APS are promising; however, without rigorous clinical trials or regulation from governing bodies, liability and user safety continue to be central concerns for stakeholders. Despite DIY APS having been used for several years now, there are no guidelines to assist users and healthcare professionals in addressing DIY APS use in routine clinical care. This commentary reports key stakeholders{\textquoteright} perspectives presented at the annual Advanced Technologies and Treatments in Diabetes conference in February 2020. Important considerations to inform the development of clinical care guidelines are also presented to generate further debate.",

author = "Shepard, {Jaclyn A} and Marc Breton and Revital Nimri and Joseph Roberts and Timothy Street and David Klonoff and Katharine Barnard-Kelly",

year = "2020",

month = oct,

day = "1",

doi = "https://doi.org/10.1177/1932296820957728",

language = "English",

journal = "Journal of Diabetes Science and Technology",

issn = "1932-2968",

publisher = "SAGE Publications",

}

TY - JOUR

T1 - User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines

AU - Shepard , Jaclyn A

AU - Breton , Marc

AU - Nimri , Revital

AU - Roberts, Joseph

AU - Street , Timothy

AU - Klonoff , David

AU - Barnard-Kelly , Katharine

PY - 2020/10/1

Y1 - 2020/10/1

N2 - A growing number of individuals with type 1 diabetes are choosing to use “do-it-yourself” artificial pancreas systems (DIY APS) to support their diabetes self-management. Observational and self-report data of glycemic benefits of DIY APS are promising; however, without rigorous clinical trials or regulation from governing bodies, liability and user safety continue to be central concerns for stakeholders. Despite DIY APS having been used for several years now, there are no guidelines to assist users and healthcare professionals in addressing DIY APS use in routine clinical care. This commentary reports key stakeholders’ perspectives presented at the annual Advanced Technologies and Treatments in Diabetes conference in February 2020. Important considerations to inform the development of clinical care guidelines are also presented to generate further debate.

AB - A growing number of individuals with type 1 diabetes are choosing to use “do-it-yourself” artificial pancreas systems (DIY APS) to support their diabetes self-management. Observational and self-report data of glycemic benefits of DIY APS are promising; however, without rigorous clinical trials or regulation from governing bodies, liability and user safety continue to be central concerns for stakeholders. Despite DIY APS having been used for several years now, there are no guidelines to assist users and healthcare professionals in addressing DIY APS use in routine clinical care. This commentary reports key stakeholders’ perspectives presented at the annual Advanced Technologies and Treatments in Diabetes conference in February 2020. Important considerations to inform the development of clinical care guidelines are also presented to generate further debate.

U2 - https://doi.org/10.1177/1932296820957728

DO - https://doi.org/10.1177/1932296820957728

M3 - Article

SN - 1932-2968

JO - Journal of Diabetes Science and Technology

JF - Journal of Diabetes Science and Technology

ER -

User and Healthcare Professional Perspectives on Do-It-Yourself Artificial Pancreas Systems: A Need for Guidelines

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this